Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders

被引:3
|
作者
Jacobs, Alicia A. [1 ]
Cangiano, Michelle [1 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Family Med, 235 Rowell,106 Carrigan Dr, Burlington, VT 05405 USA
来源
PRIMARY CARE | 2018年 / 45卷 / 04期
关键词
Opioid-use disorder (OUD); Opioid addiction; Medication-assisted therapy (MAT); Trauma-informed care; Buprenorphine; Hub-and-spoke model; Harm reduction; ABUSE SCREENING-TEST; BUPRENORPHINE; OUTCOMES; DEPENDENCE; METHADONE; GENDER; MODEL; CARE;
D O I
10.1016/j.pop.2018.08.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Opioid addiction rates are at a national high, with significant morbidity and mortality. In women, rates have been steadily increasing to be at par with addiction rates in men. Women tend to have quicker addiction and shorter duration to adverse outcomes. Treatment of women has the best outcomes when it is gender-specific, trauma-informed, connected with access to psychiatric services, and integrated into the medical home. Improved outcomes can be achieved with coordinated systems of care based on the harm-reduction model, with integration of medication-assisted therapy in a patient-centered medical home.
引用
收藏
页码:731 / +
页数:13
相关论文
共 50 条
  • [41] Medication-Assisted Treatment (MAT) in pregnancy: methadone and buprenorphine
    Staszewski, Cara
    Herrera, Kimberly
    Persad, Malini D.
    Ly, Victoria
    Garretto, Diana
    Davis, Jay
    Garry, David J.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S219 - S220
  • [42] Medication-Assisted Treatment for Opioid-Use Disorder
    Oesterle, Tyler S.
    Thusius, Nuna J.
    Rummans, Teresa A.
    Gold, Mark S.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (10) : 2072 - 2086
  • [43] National Overview of Medication-Assisted Treatment for American Indians and Alaska Natives With Substance Use Disorders
    Rieckmann, Traci
    Moore, Laurie
    Croy, Calvin
    Aarons, Gregory A.
    Novins, Douglas K.
    [J]. PSYCHIATRIC SERVICES, 2017, 68 (11) : 1136 - 1143
  • [44] The NP and medication-assisted treatment for opioid use disorder
    Warner, Shirley A.
    Strickland, Daniel M.
    [J]. NURSE PRACTITIONER, 2022, 47 (07): : 10 - 13
  • [45] Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders
    Brunisholz, Kimberly D.
    Knighton, Andrew
    Sharma, Amulya
    Nichols, Lisa
    Reisig, Kristen
    Burton, Jed
    Scovill, Debbie
    Tometich, Carolyn
    Foote, Mark
    Read, Shelly
    Whittle, Scott
    [J]. PROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTION, 2020, 14 (01) : 5 - 6
  • [46] Author Correction: Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
    Igor Elman
    Margaret Howard
    Jacob T. Borodovsky
    David Mysels
    David Rott
    David Borsook
    Mark Albanese
    [J]. Scientific Reports, 10
  • [47] Medication-assisted therapies for opioid use disorders in patients with chronic pain
    Oesterle, Tyler S.
    Kolla, Bhanu Prakash
    Rummans, Teresa A.
    Gold, Mark S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 411
  • [48] Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
    Emma A. van Reekum
    Tea Rosic
    Jacqueline Hudson
    Nitika Sanger
    David C. Marsh
    Andrew Worster
    Lehana Thabane
    Zainab Samaan
    [J]. Biology of Sex Differences, 11
  • [49] Recommendations for benzodiazepine use and detoxification for patients in medication-assisted (substitution) treatment programmes for opioid addiction in the Republic of Slovenia
    Kastelic, Andrej
    Segrec, Nusa
    [J]. ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (10): : 629 - 634
  • [50] Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder in the United States
    MacAfee, Lauren
    Sawyer, Anne
    Terplan, Mishka
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E125 - E125